California Public Employees Retirement System
UBX

California Public Employees Retirement System’s Unity Biotechnology UBX Stock Holding History

California Public Employees Retirement System’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,910
Closed -$415K – 2842
2021
Q1 		$415K Hold
6,910
– – ﹤0.01% 3063
2020
Q4 		$362K Hold
6,910
– – ﹤0.01% 3104
2020
Q3 		$239K Buy
6,910
+250
+4% +$15.8K ﹤0.01% 3188
2020
Q2 		$578K Buy
6,660
+3,675
+123% +$273K ﹤0.01% 2602
2020
Q1 		$173K Hold
2,985
– – ﹤0.01% 2915
2019
Q4 		$215K Buy
2,985
+1,370
+85% +$96.7K ﹤0.01% 3086
2019
Q3 		$99K Hold
1,615
– – ﹤0.01% 3092
2019
Q2 		$153K Buy
+1,615
New +$137K ﹤0.01% 3001

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System's UBX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 6,910 shares — an estimated $415K sold.

California Public Employees Retirement System first reported a position in UBX in Q2 2019 and held it in 8 quarters. The position peaked at $578K in Q2 2020. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 6,910 Unity Biotechnology shares in Q2 2021, an estimated $415K.
  • California Public Employees Retirement System first reported a position in Unity Biotechnology in Q2 2019 and held it in 8 quarters.
  • California Public Employees Retirement System's Unity Biotechnology position peaked at $578K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.